National Research Corporation Reports Q1 2025 Results and Announces Share Repurchase Program

NRC HEALTH

2025-Q1 EPS reported $0.25 revenue$33,551,000

Total recurring value contract value increased sequentially for second consecutive quarter.
Board approved repurchase of up to one million additional shares of common stock.
Declared quarterly cash dividend of $0.12 per share payable July 11, 2025.
Operating expenses declined in the first quarter of 2025.
Trent Green to join as CEO in June 2025; introductory calls available June 9-10.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.